Ingenia Therapeutics Inc.
Funding rounds
3 counted as startup funding. Open the number of investors for the round's details.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Ingenia Therapeutics Inc. chose not to state its revenue in its newest notice of a funding round (Jun 2024).
SEC Form D · Jun 2024
The industry group it chose in its notices: Biotechnology.
SEC Form D · Jun 2024
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
No investor of Ingenia Therapeutics Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Sangyeul Han | Executive officer | Jun 2024 |
| Minji Kim | Executive officer | Sep 2020 |
| Eric Furfine | Director | Jun 2024 |
| Joo Hee Kwak | Director | Jun 2024 |
| Kwang Ho Cheong | Director | Jun 2024 |
| Sang Gyun Kim | Director | Jun 2024 |
| Sangyeul Han | Director | Jun 2024 |
| Heewon Park | Director | Nov 2022 |
| Sung Jae Kim | Director | Nov 2022 |
| Minji Kim | Director | Sep 2020 |